After a period of significant expansion, medical device manufacturer Integer is navigating a transitional year in 2026. The ...

Analysts' ratings for Integer Holdings (NYSE:ITGR) over the last quarter vary from bullish to bearish, as provided by 7 analysts. The following table encapsulates their recent ratings, offering a ...

Medical technology company Integer Holdings (NYSE:ITGR) will be reporting results this Thursday morning. Here’s what you need to know.

Shares of medical technology company Integer Holdings (NYSE:ITGR) jumped 4.2% in the morning session after the company reported better-than-expected fourth-quarter 2025 revenue and earnings, alongside ...

Integer projects 2025 sales growth between 8% and 10%, with organic growth of 6% to 8%. This growth is expected to be driven by continued above-market performance and contributions from recent ...